East Fork Cultivars was cited for selling unapproved new drugs and misbranded products in violation of the Federal Food, Drug, and Cosmetic Act, specifically CBD products including Rescue Rub CBD, CBD Oil, and Peak CBD Solution tinctures marketed through their websites and social media. The FDA determined these products violated sections 505(a) and 301(d) (unapproved new drug introduction into interstate commerce) and section 502(f)(1) (misbranding) based on disease claims and structure/function claims observed on the company's websites and social media platforms. The violations were identified during an FDA review of the company's websites in September 2023, where the agency found therapeutic claims such as references to COVID-19 that established the products' intended use as drugs rather than dietary supplements.